Glutethimide (Doriden®) was introduced in 1954 and methaqualone ("Quaalude" Sopor®) in 1965 as safe barbiturate substitutes. Experience demonstrated, however; that their addiction liability and the severity of withdrawal symptoms were similar to those of barbiturates. By 1972, "luding out," taking methaqualone with wine, was a popular college pastime. Excessive use leads to tolerance, dependence, and withdrawal symptoms similar to those of barbiturates. In the United States, the marketing of methaqualone pharmaceutical products stopped in 1984, and methaqualone was transferred to Schedule I of the CSA. In 1991, glutethimide was transferred into Schedule II in response to an upsurge in the prevalence of diversion, abuse, and overdose deaths. Today, there is little medical use of glutethimide in the United States.
Source: DEA
Get the APP
If it is not on the Android Market now, it will be soon.
APPs are available on over 1285 Android Phones, Tablets and other devices.
APPs have more images and information and are always available. You can't lose them and they are updated for free when new information and images become available. Visit the Android Market and test one of the free APPs. Just enter Streetdrugs.org into the search bar.
There are many educational products at market. The Drug ID Guide, Meth Production Chart, and the other brochures are used by many law enforcement agencies around the world to educate their officers on the types of drugs they will encounter on the street. Why do they choose our products? Because they provide the most accurate and current information accompanied with high resolution images of the illegal drugs seized by law enforcement officers. Hospital emergency rooms, elementary schools, universities and thousands of businesses use our products to educate their students and staff as to the dangers of illegal drug use as well as prescription drug abuse. Visit the market to see what is available for you.
dependence, and withdrawal symptoms similar to those of barbiturates. In the United States, the marketing of methaqualone pharmaceutical products stopped in 1984, and methaqualone was transferred to Schedule I of the CSA. In 1991, glutethimide was transferred into Schedule II in response to an upsurge in the prevalence of diversion, abuse, and overdose deaths. Today, there is little medical use of glutethimide in the United States. 
